Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015574 · ClinicalTrials.gov registry record
Air Pollution and Implantable Cardioverter Defibrillators
A clinical trial of Arrythmias, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT00015574: Completed study of Arrythmias, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00015574 is a study of Arrythmias that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00015574, a study of Arrythmias, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Community based studies have shown increased cardiovascular mortality associated with acute exposures to particulate air pollution. Electrocardiographic changes have also been reported in animals exposed to particles in controlled conditions. We have hypothesized that cardiovascular patients may experience life-threatening arrhythmias associated with particulate air pollution episodes. Implanted cardioverter defibrillator (ICD) devices continuously monitor the heart rhythm, and on detecting arrhythmias can initiate interventions. These devices provide a passive, continuous monitor of cardiac arrhythmias. We are assessing the association between community exposures to air pollution measured by ambient monitors and these cardiac arrhythmias detected by implanted cardioverter defibrillator devices.
Conditions Studied
Study Locations (1)
Massachusetts
- New England Medical Center, Cardiac Arrhythmia Service - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 1998-09 |
| Est. Completion | 2004-09 |
What the finished NCT00015574 record still lists
NCT00015574 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Arrythmias appearing as the primary indexed condition, and to 0 interventions.
NCT00015574 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00015574 about?
NCT00015574 is a clinical study titled "Air Pollution and Implantable Cardioverter Defibrillators". Community based studies have shown increased cardiovascular mortality associated with acute exposures to particulate air pollution. Electrocardiographic changes have also been reported in animals exposed to particles in controlled conditions. We have hypothesized that cardiovascular patients may exp...
What is the current status of trial NCT00015574?
This trial is currently completed. The enrollment target is 500 participants. The study started on 1998-09. Estimated completion is 2004-09.
What conditions does trial NCT00015574 study?
This clinical trial studies the following conditions: Arrythmias.
Who is sponsoring clinical trial NCT00015574?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00015574 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia